Table 4.
The mortalities based on the mode of treatment for the patients
| Mode of treatment (total cases treated) | Number of deaths (%) |
|---|---|
| Supportive therapy only (15 cases) | 3 (20%) |
| The treatment regimen | |
| MDAC in the regimen (27 cases) | 5 (18.5%) |
| NAC in the regimen (35 cases) | 12 (34.3%) |
| Pen G in the regimen (18 cases) | 4 (22.2%) |
| Oral silymarin in the regimen (8 cases) | 1 (12.5%) |
| Single therapy | |
| NAC alone (7 cases) | 4 (57.1%) |
| Oral silymarin alone (1 case) | 0 (0%) |
| MDAC alone (1 case) | 0 (0%) |
| Double therapy | |
| MDAC + NAC (7 cases) | 3 (42.9%) |
| MDAC + Pen G (2 cases) | 0 |
| NAC + Pen G (3 cases) | 3 (100%) |
| Oral silymarin + NAC (2 cases) | 0 |
| Triple and quadruple therapy | |
| MDAC + NAC + Pen G (12 cases) | 1 (8.3%) |
| Oral silymarin + MDAC + NAC (4 cases) | 1 (25%) |
| Oral silymarin + MDAC + NAC + Pen G (1 case) | 0 |
Abbreviations: MDAC, multiple-dose activated charcoal; NAC, N-acetylcysteine intravenous; Pen G, penicillin G; Oral silymarin, oral high dose silymarin.